Panitumumab Injection - Drug Information
Generic Name : Panitumumab Injection
Pronunciation : PAN-i-TOOM-ue-mab
ICD Code : Y43.4 | Therapeutic Classification : Monoclonal antibodies
Trade Name(s) :
International - Vectibix.
Why is Panitumumab Injection Prescribed? (Indications)
This medication is a monoclonal antibody, prescribed for colon or rectal cancer. It slows or stops cancer cell growth.
When should Panitumumab Injection not to be taken? (Contraindications)
Hypersensitivity.What is the dosage of Panitumumab Injection?
IV- The recommended dose is 6 mg/kg, every 14 days.
How should Panitumumab Injection be taken?
It comes as a solution for injection, to be administered by a healthcare provider into the vein.
What are the warnings and precautions for Panitumumab Injection?
* Caution should be exercised in patients with history of diarrhea, dehydration, lung disease, skin problem, stomach problem, who are taking other medications, children, during pregnancy and breastfeeding.* Avoid exposure to sunlight.
What are the side effects of Panitumumab Injection?
Most Common - Decreased level of manganese in blood, nail disorder, fatigue, abdominal pain, nausea, and diarrhea.Most Serious - Blood clot in lugs.
Gastrointestinal - Constipation, vomiting, mouth ulcer, mouth inflammation.
Metabolic - Swelling in the extremities.
Respiratory - ♦ Cough and Pulmonary Fibrosis/Interstitial Lung Disease.
Skin - Redness of the skin, skin inflammation, itching, rash, skin fissures, pimples, dry skin.
Eye - Growth of eyelashes.